Anti-Migration System for Anti-reflux Oeso-gastric Stent (ANTIMIG)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-91
SponsorSociété Française d'Endoscopie Digestive
About this trial
The aim of this prospective, controlled, randomized, multicentre, single-blind study is to compare the rate of intragastric migration of 2 types of esophageal stents with and without an anti-migration device placed for locally advanced or metastatic malignant stenosis of the gastroesophageal junction.
Eligibility criteria
Qualifiers
Patient of both sexes aged 18 or over.
Patient admitted to one of the investigation centers for dysphagia due to tumoral stenosis of the gastroesophageal junction, locally advanced or metastatic.
Patient ASA 1, ASA 2, ASA 3
Absence of participation in another clinical study
Disqualifiers
Patient referred for stenosis by extrinsic compression by an extra digestive mass
Patients with contraindications relating to the procedures essential for the introduction of a stent
Mediastinal radiotherapy or esophageal surgery history
Patient under 18 or over 90
Trial design
Treatments tested in this trial
- Gastroesophageal stent placement
Treatment groups
180 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov